Herb Pharm unveils new logo and label design, launches three herbal supplements
WILLIAMS, Ore. — Herb Pharm recently debuted a new logo and label design across its entire product line in conjunction with the launch of three new herbal supplements — Inflamma Response capsules, Passionflower capsules and Turmeric softgels.
The new scheme makes use of color-coded functional categories that are easy to spot and understand. The new color-coded system enables retailers to merchandise products by category, while also providing consumers an at-a-glance reference point intended to educate, facilitate product selection and eliminate confusion.
“We hear from so many people saying they have both a need and interest in healing herbs but simply don’t know where to start,” stated Michael Gillette, director of marketing at Herb Pharm. “With our new color-coded labels and corresponding descriptive categories, we are making it easy to match an individual’s health need with an effective, medicinal herb, while also encouraging the experienced herb shopper to broaden their use of herbs to other areas of their personal health.”
With the new packaging, Herb Pharm’s single herbs and multi-herb compounds are organized into the following color-coded categories based on their primary function: Immune Support, Nervous System, Energy & Vitality, Respiratory System, System Restoration, Cleanse & Detoxify and Optimal Well-Being.
In addition, the new Herb Pharm logo features a cleaner, more contemporary appearance, while also paying homage to the Greek mythological symbol known as the Rod of Asclepius, who was the Greek deity representing the healing arts and medicine. Normally depicted as a staff entwined with a single serpent, the serpent has been replaced with a climbing vine and leaves to symbolize the botanical origins of Herb Pharm’s products.
Regarding the new product launches, Inflamma Response capsules retail for a suggested $28 and are made from a blend of the Ayurvedic herbs turmeric, boswellia and ginger, with the added support of traditional Chinese healing herbs, reishi mushroom and bupleurum. Retailing for a suggested $20, Passionflower capsules are made with a combination of flowering passionflower herb extract and certified organic whole herb and is traditionally used as a calming herb in Europe and the Americas. And Turmeric softgels, which retails for a suggested $28, are made from a formula of certified organic extracts of whole turmeric root, as well as organic black pepper extract.
“With both the new products and the new look, we are trying to make our efficacious herbal supplements more accessible to a broader range of consumers,” Gillette said. “The new herbal capsules and softgel will provide those consumers with an easier and more familiar way to take safe, effective herbal supplements.”
Safeway announces final distribution ratio for Blackhawk Network Holdings stock
PLEASANTON, Calif. — Safeway on Tuesday announced the final distribution ratio for the previously announced special stock dividend to its stockholders of all of the shares of Class B common stock of Blackhawk Network Holdings held by Safeway.
Safeway stockholders will receive 0.164291 of a share of Blackhawk Class B common stock for every share of Safeway common stock held as of the close of business on April 3, 2014.
The distribution will be made on April 14, 2014 in the form of a pro rata distribution of all of the 37.8 million shares of Class B common stock of Blackhawk owned by Safeway to all Safeway stockholders of record on the record date. No fractional shares of Blackhawk Class B common stock will be distributed. Instead, Safeway stockholders will receive cash in lieu of any fraction of a share of Blackhawk Class B common stock that they otherwise would have received.
CVS Caremark finalizes previously announced settlement with SEC
WOONSOCKET, R.I. — CVS Caremark announced on Tuesday that it has finalized with the Securities and Exchange Commission a settlement that was previously announced in August 2013.
The settlement was entered into on a "no admit or deny basis" and will not require CVS Caremark to restate its earnings for any reporting period. The company stated that the matter is now fully resolved.
As previously announced last year when the company disclosed that it had reached an agreement in principle with the staff of the SEC, the settlement relates to events that occurred in the third and fourth quarters of 2009, including certain public disclosures made by the company and certain aspects of the purchase accounting adjustment related to the October 2008 Longs Drug Stores acquisition.